Medicare Enrolled
Dr. Bela Ajtai, MD, PHD
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ajtai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ajtai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ajtai
Dr. Bela Ajtai is a neurology specialist in Amherst, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ajtai performed 131,635 Medicare services across 2,940 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ajtai received a total of $133,947 from 45 pharmaceutical and/or device companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ajtai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in NY
$133,947 industry payments
Medicare Practice Summary
Medicare Utilization ↗131,635
Medicare services
Top 0% in NY for neurology
2,940
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,928 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 42,560 | $38 | $65 |
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
28,515 | $16 | $26 |
| Ocrelizumab infusion (Ocrevus) for MS | 22,806 | $46 | $86 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
11,705 | $26 | $128 |
| Injection, eptinezumab-jjmr, 1 mg | 8,500 | $13 | $30 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
6,400 | $34 | $75 |
| Gadobenate dimeglumine injection An injection of gadobenate dimeglumine, a contrast agent used to enhance imaging results. |
1,335 | $1 | $7 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,283 | $0 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
1,109 | $16 | $53 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
836 | $47 | $125 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
807 | $96 | $220 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
637 | $4 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
449 | $11 | $34 |
| Anti-nausea injection (ondansetron/Zofran) | 432 | $0 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
396 | $21 | $50 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
380 | $1 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
371 | $88 | $150 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
360 | $0 | $1 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
317 | $0 | $2 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
310 | $55 | $125 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
300 | $21 | $53 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
214 | $1 | $3 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
169 | $142 | $607 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
144 | $8 | $40 |
| New patient office visit, complex (60-74 min) | 115 | $136 | $275 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
112 | $2 | $14 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
111 | $10 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $65 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $109 | $225 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 101 | $168 | $370 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
93 | $1 | $10 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
76 | $55 | $185 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
69 | $234 | $1,285 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
66 | $4 | $50 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
58 | $160 | $615 |
| Platelet aggregation function test A blood test that measures how well platelets clump together. It evaluates the function of platelets in the blood clotting process. |
52 | $24 | $53 |
| MRI of head blood vessels with and without contrast An MRI scan that uses contrast dye to create detailed images of the blood vessels in the head, performed both before and after the dye is administered. |
40 | $241 | $1,070 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
40 | $6 | $19 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
29 | $114 | $615 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
25 | $145 | $662 |
| MRI of neck blood vessels with and without contrast This procedure uses magnetic resonance imaging to create detailed pictures of the blood vessels in the neck. Images are taken both before and after the administration of a contrast dye to enhance visibility. |
24 | $269 | $1,070 |
| CT scan of head/brain, without contrast A CT scan uses X-rays to create detailed images of the head or brain without the use of contrast dye. |
21 | $78 | $271 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
21 | $18 | $159 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
16 | $4 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
13 | $6 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $118 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.2% high complexity
42.9% medium
0.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$133,947
Total received (2018-2024)
Avg $19,135/year across 7 years
Top 6% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
615
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$118,645 (88.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,544 (7.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,758 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$99,111
2023
$5,185
2022
$1,647
2021
$21,764
2020
$3,922
2019
$1,428
2018
$889
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$74,685
Eisai Inc.
$23,351
ABBVIE INC.
$232
Otsuka America Pharmaceutical, Inc.
$218
PFIZER INC.
$178
UCB, Inc.
$112
Teva Pharmaceuticals USA, Inc.
$77
Kyowa Kirin, Inc.
$50
Alexion Pharmaceuticals, Inc.
$45
Neurocrine Biosciences, Inc.
$43
Lundbeck LLC
$40
GE HEALTHCARE
$28
CATALYST PHARMACEUTICALS, INC.
$21
Alnylam Pharmaceuticals Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Top 3 companies account for 99.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$74,786
Eisai Inc.
$23,367
Biogen, Inc.
$23,249
US Oncology Corporate, Inc.
$1,752
Corium, LLC
$1,723
Avanir Pharmaceuticals, Inc.
$1,448
Teva Pharmaceuticals USA, Inc.
$1,442
PFIZER INC.
$697
ACADIA Pharmaceuticals Inc
$551
Otsuka America Pharmaceutical, Inc.
$483
AbbVie Inc.
$460
Novartis Pharmaceuticals Corporation
$460
Kyowa Kirin, Inc.
$400
Amgen Inc.
$371
Adamas Pharmaceuticals, Inc.
$317
ABBVIE INC.
$308
Neurocrine Biosciences, Inc.
$303
Lundbeck LLC
$264
Alexion Pharmaceuticals, Inc.
$234
UCB, Inc.
$212
Alnylam Pharmaceuticals Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$126
ARBOR PHARMACEUTICALS, INC.
$110
Biohaven Pharmaceutical Holding Company Ltd.
$84
E.R. Squibb & Sons, L.L.C.
$81
GE HealthCare
$55
US WorldMeds, LLC
$54
Biohaven Pharmaceuticals, Inc.
$53
GlaxoSmithKline, LLC.
$52
MITSUBISHI TANABE PHARMA AMERICA, INC.
$50
AstraZeneca Pharmaceuticals LP
$43
Allergan, Inc.
$42
Impax Laboratories, Inc.
$34
GE HEALTHCARE
$31
Boston Scientific Corporation
$30
Abbott Laboratories
$22
CATALYST PHARMACEUTICALS, INC.
$21
Bayer HealthCare Pharmaceuticals Inc.
$16
Alkermes, Inc.
$14
Janssen Biotech, Inc.
$13
CSL Behring
$13
Mitsubishi Tanabe Pharma America, Inc.
$13
GENZYME CORPORATION
$12
Allergan Inc.
$11
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 90.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPLATZER TALISMAN · AMYVID · APOKYN · ARISTADA · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRILINTA · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · ELIQUIS · EMGALITY · FIRDAPSE · GOCOVRI · Hizentra · Horizant · INFLECTRA · INGREZZA · KISUNLA · Leqembi · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ORENCIA · Ongentys · PANZYGA · QULIPTA · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Repatha · Rystiggo · SOLIRIS · STELARA · Soliris · TECFIDERA · TRINTELLIX · Trintellix · UBRELVY · ULTOMIRIS · VYEPTI · WATCHMAN Access System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ajtai is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ajtai experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. Ajtai performed 42,560 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ajtai receive payments from pharmaceutical companies?
Yes. Dr. Ajtai received a total of $133,947 from 45 companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ajtai's costs compare to other neurologists in Amherst?
Dr. Ajtai's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ajtai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology